Interleukin 1B and Interleukin 1RN Polymorphisms Are Associated with Increased Risk of Gastric Carcinoma
Overview
Authors
Affiliations
Background & Aims: Interleukin (IL)-1 gene cluster proinflammatory polymorphisms have been associated with development of gastric atrophy and with increased risk of gastric carcinoma. We aimed to determine the association between IL-1 loci polymorphisms and increased risk of gastric carcinoma in samples from a Portuguese population, and to find whether there was any relationship with the histologic types of gastric carcinoma.
Methods: In a case-control study including 220 controls and 152 patients with gastric carcinoma (intestinal, 76; diffuse, 37; and atypical, 39), both the IL-1B-511 biallelic polymorphism and the IL-1RN penta-allelic variable number of tandem repeats were genotyped.
Results: We found a significant association between the IL-1 polymorphisms and increased risk for tumor development in patients with intestinal-type gastric carcinoma. A trend towards an increased risk of tumor development was also observed in patients with diffuse-type gastric carcinoma. No significant relationship was observed in patients with atypical carcinoma. Carriers of IL-1B-511T and IL-1RN*2 homozygotes had increased risk for developing intestinal-type gastric carcinoma with odds ratios of 2.7 (95% confidence interval [CI], 1.5-4.9) and 3.1 (95% CI, 1.5-6.5), respectively. Statistical analysis showed an interaction between the 2 loci with the risk conferred by the IL-1B-511T allele substantially increased (odds ratio, 9.0; 95% CI, 3.5-23.0) in individuals homozygous for the IL-1RN*2 allele.
Conclusions: Our results provide further support to the association between IL-1 gene cluster proinflammatory polymorphisms and increased risk of gastric carcinoma. Furthermore, we found evidence pointing to the existence of a synergistic interaction between the IL-1B and IL-1RN polymorphisms.
Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas.
Ding Y, Yi J, Wang J, Sun Z Heliyon. 2023; 9(4):e14960.
PMID: 37025835 PMC: 10070157. DOI: 10.1016/j.heliyon.2023.e14960.
Inflammation and Gastric Cancer.
Jaroenlapnopparat A, Bhatia K, Coban S Diseases. 2022; 10(3).
PMID: 35892729 PMC: 9326573. DOI: 10.3390/diseases10030035.
The Interplay between Tumour Microenvironment Components in Malignant Melanoma.
Amalinei C, Grigoras A, Lozneanu L, Caruntu I, Giusca S, Balan R Medicina (Kaunas). 2022; 58(3).
PMID: 35334544 PMC: 8953474. DOI: 10.3390/medicina58030365.
The Immunogenetics of Melanoma.
Darbeheshti F Adv Exp Med Biol. 2022; 1367:383-396.
PMID: 35286704 DOI: 10.1007/978-3-030-92616-8_15.
Rebe C, Ghiringhelli F Cancers (Basel). 2020; 12(7).
PMID: 32635472 PMC: 7408158. DOI: 10.3390/cancers12071791.